Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum microRNA expression profiling in patients with multiple system atrophy

7 Nov 2017

Abstract excerpt

Multiple system atrophy (MSA) is a sporadic neurodegenerative disease that is pathologically characterized by α‑synuclein positive glial cytoplasmic inclusions in oligodendrocytes. The clinical diagnosis of MSA is often challenging as there are no established biomarkers and diagnoses are now based on clinical findings alone. At present, the etiology and pathogenesis of MSA are unclear. It has been reported that...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Nuclear Receptors and Signaling
Share to Parkinson's Disease Mechanisms and Treatments
Share to RNA regulation and disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29115515
DOI: 10.3892/mmr.2017.7995

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum microRNA expression profiling in patients with multiple system atrophyPMID 29115515Read ↗

MicroRNA-101 Modulates Autophagy and Oligodendroglial Alpha-Synuclein Accumulation in Multiple System AtrophySemantic proximity Read ↗

MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson’s Disease and Multiple System AtrophySemantic proximity Read ↗

Serum miR-96-5P and miR-339-5P Are Potential Biomarkers for Multiple System Atrophy and Parkinson's DiseaseSemantic proximity Read ↗

MicroRNAs (miRNAs) as Biomarkers for Diagnosis, Prognosis, or as Therapeutics Molecules in Neurodegenerative DiseasesSemantic proximity Read ↗

Aberrant Expression of Circulating MicroRNA Leads to the Dysregulation of Alpha-Synuclein and Other Pathogenic Genes in Parkinson’s DiseaseSemantic proximity Read ↗

The role of miRNA in motor neuron diseaseSemantic proximity Read ↗

Common signatures of differential microRNA expression in Parkinson’s and Alzheimer’s disease brainsSemantic proximity Read ↗

Transcriptional profiling of Multiple System Atrophy cerebellar tissue highlights differences between the parkinsonian and cerebellar sub-types of the diseaseSemantic proximity Read ↗

Plasma miRNA Biomarker Signatures in Parkinsonian SyndromesSemantic proximity Read ↗

ROLE OF MICRORNAS IN THE PATHOGENESIS OF PARKINSON'S DISEASESemantic proximity Read ↗

The genetic basis of multiple system atrophySemantic proximity Read ↗

Gene expression changes in postmortem tissue from the rostral pons of multiple system atrophy patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.